Clinical Trial Update: Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

View source ↗

Summary

A completed clinical trial evaluating the validation of Lophius T-Track CMV and T-Track EBV kits in hemodialysis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• T-Track CMV (CMV T-cell assay kit)
• T-Track EBV (EBV T-cell assay kit)

Snippet

Sponsor: Lophius Biosciences GmbH | Conditions: Renal Failure Chronic Requiring Dialysis | Status: COMPLETED